Patent Assignment
Reel/Frame 051062/0905
Assignment of Assignor's Interest
Recorded: 2019-11-20
Pages: 11
Assignor
XCYTE THERAPIES, INC.
Executed: 2005-12-14
Assignee
INVITROGEN CORPORATION
5791 VAN ALLEN WAY, CARLSBAD, CALIFORNIA, 92008
Covered Property
(1)
Methods for Eliminating at Least a Substantial Portion of a Clonal Antigen-Specific Memory T Cell Subpopulation
Application:
16/534,658 →
Publication:
US 2020/0071663
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 20, 2019
From: BERENSON, RONALD J.; BONYHADI, MARK; KALAMASZ, DALE
To: XCYTE THERAPIES, INC.
Reel/Frame 051062/0797 →
Merger and Change of Name
Nov 20, 2019
From: INVITROGEN CORPORATION; LT NAME CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 051063/0045 →